DrugPatentWatch Database Preview
Corcept Therap Company Profile
What is the competitive landscape for CORCEPT THERAP, and what generic alternatives to CORCEPT THERAP drugs are available?
CORCEPT THERAP has one approved drug.
There are four US patents protecting CORCEPT THERAP drugs.
There are five patent family members on CORCEPT THERAP drugs in five countries.
Summary for Corcept Therap
| International Patents: | 5 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Corcept Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | RX | Yes | Yes | 9,829,495 | ➤ Sign Up | ➤ Sign Up | ||||
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | RX | Yes | Yes | 9,943,526 | ➤ Sign Up | ➤ Sign Up | ||||
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | RX | Yes | Yes | 8,921,348 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Corcept Therap
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,598,149 | Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Corcept Therap Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2994422 | ➤ Sign Up |
| South Korea | 20180052120 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2017027851 | ➤ Sign Up |
| Australia | 2016305092 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.
